Deep Track Capital, LP
67 holdingsFiling period: 2026-06-30Current AUM: $6.57Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | GH | Guardant Health Inc | 3.39M | $509.1M | $619.6M | 9.43% | +55.1K | 2026-06-30 |
| 2 | IMVT | Immunovant Inc | 9.34M | $359.9M | $274.8M | 4.18% | -2,185,820 | 2026-06-30 |
| 3 | GPCR | Structure Therapeutics Inc | 4.74M | $254.4M | $101.8M | 1.55% | +460.2K | 2026-06-30 |
| 4 | PCVX | Vaxcyte Inc | 4.30M | $250.0M | $264.3M | 4.02% | -- | 2026-06-30 |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | 825.0K | $248.3M | $191.7M | 2.92% | -- | 2026-06-30 |
| 6 | MANE | Veradermics Inc | 2.00M | $245.9M | $287.7M | 4.38% | +1.50M | 2026-06-30 |
| 7 | GMAB | Genmab A/S | 8.65M | $237.6M | $495.6M | 7.54% | +4.99M | 2026-06-30 |
| 8 | TARS | Tarsus Pharmaceuticals Inc | 3.67M | $230.8M | $264.2M | 4.02% | +66.8K | 2026-06-30 |
| 9 | NUVL | Nuvalent Inc | 1.78M | $220.2M | $220.2M | 3.35% | +407.0K | 2026-06-30 |
| 10 | — | Alkermes PLC | 4.00M | $209.6M | $209.6M | 3.19% | +409.7K | 2026-06-30 |
| 11 | OCUL | Ocular Therapeutix Inc | 19.69M | $193.3M | $143.5M | 2.18% | -- | 2026-06-30 |
| 12 | BMRN | Biomarin Pharmaceutical Inc | 3.31M | $189.3M | $185.2M | 2.82% | +2.16M | 2026-06-30 |
| 13 | NRIX | Nurix Therapeutics Inc | 7.74M | $187.7M | $210.9M | 3.21% | +1.39M | 2026-06-30 |
| 14 | ORKA | Oruka Therapeutics Inc | 1.93M | $183.3M | $184.8M | 2.81% | -108,203 | 2026-06-30 |
| 15 | ALMS | Alumis Inc | 6.35M | $178.6M | $45.3M | 0.69% | -424,037 | 2026-06-30 |
| 16 | IONS | Ionis Pharmaceuticals Inc | 2.20M | $174.4M | $98.8M | 1.50% | +250.0K | 2026-06-30 |
| 17 | CMPS | Compass Pathways PLC | 12.16M | $172.1M | $149.3M | 2.27% | -- | 2026-06-30 |
| 18 | VERA | Vera Therapeutics Inc | 4.00M | $171.6M | $123.8M | 1.88% | -106,067 | 2026-06-30 |
| 19 | AXSM | Axsome Therapeutics Inc. | 700.0K | $171.3M | $100.5M | 1.53% | -400,000 | 2026-06-30 |
| 20 | MLTX | Moonlake Immunotherapeutics | 7.00M | $136.3M | $86.2M | 1.31% | +590.2K | 2026-06-30 |
| 21 | COAG | Hemab Therapeutics Hldgs Inc | 3.60M | $132.3M | $138.7M | 2.11% | -- | 2026-06-30 |
| 22 | TNGX | Tango Therapeutics Inc | 4.20M | $131.3M | $93.4M | 1.42% | +1.45M | 2026-06-30 |
| 23 | DFTX | Definium Therapeutics Inc | 2.75M | $129.4M | $104.8M | 1.59% | -250,000 | 2026-06-30 |
| 24 | GRAL | Grail Inc | 1.83M | $125.3M | $289.7M | 4.41% | +112.1K | 2026-06-30 |
| 25 | BCAX | Bicara Therapeutics Inc | 4.10M | $121.7M | $40.0M | 0.61% | +37.5K | 2026-06-30 |
← Scroll →
Page 1 of 3